These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 17425491)

  • 1. Use of nanoparticles for drug delivery in glioblastoma multiforme.
    Jain KK
    Expert Rev Neurother; 2007 Apr; 7(4):363-72. PubMed ID: 17425491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents.
    Reardon DA; Wen PY
    Oncologist; 2006 Feb; 11(2):152-64. PubMed ID: 16476836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery systems and molecular targets of mechanism-based therapies for GBM.
    Phuphanich S; Brat DJ; Olson JJ
    Expert Rev Neurother; 2004 Jul; 4(4):649-63. PubMed ID: 15853584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme.
    Nikanjam M; Gibbs AR; Hunt CA; Budinger TF; Forte TM
    J Control Release; 2007 Dec; 124(3):163-71. PubMed ID: 17964677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of nanobiotechnology in the personalized management of glioblastoma multiforme.
    Jain KK
    Nanomedicine (Lond); 2011 Apr; 6(3):411-4. PubMed ID: 21542679
    [No Abstract]   [Full Text] [Related]  

  • 6. Nanoparticles: Novel vehicles in treatment of Glioblastoma.
    Pourgholi F; Hajivalili M; Farhad JN; Kafil HS; Yousefi M
    Biomed Pharmacother; 2016 Feb; 77():98-107. PubMed ID: 26796272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted drug delivery for treatment and imaging of glioblastoma multiforme.
    Stukel JM; Caplan MR
    Expert Opin Drug Deliv; 2009 Jul; 6(7):705-18. PubMed ID: 19538036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L
    Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convection-enhanced delivery to achieve widespread distribution of viral vectors: Predicting clinical implementation.
    Debinski W; Tatter SB
    Curr Opin Mol Ther; 2010 Dec; 12(6):647-53. PubMed ID: 21154156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates.
    Simpson L; Galanis E
    Expert Rev Anticancer Ther; 2006 Nov; 6(11):1593-607. PubMed ID: 17134364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle and targeted systems for cancer therapy.
    Brannon-Peppas L; Blanchette JO
    Adv Drug Deliv Rev; 2004 Sep; 56(11):1649-59. PubMed ID: 15350294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standard treatment and experimental targeted drug therapy for recurrent glioblastoma multiforme.
    Chang SM; Butowski NA; Sneed PK; Garner IV
    Neurosurg Focus; 2006 Apr; 20(4):E4. PubMed ID: 16709035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy delivery issues in central nervous system malignancy: a reality check.
    Muldoon LL; Soussain C; Jahnke K; Johanson C; Siegal T; Smith QR; Hall WA; Hynynen K; Senter PD; Peereboom DM; Neuwelt EA
    J Clin Oncol; 2007 Jun; 25(16):2295-305. PubMed ID: 17538176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug delivery approaches for the treatment of glioblastoma multiforme.
    Fakhoury M
    Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1365-73. PubMed ID: 26046399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme.
    Nikanjam M; Blakely EA; Bjornstad KA; Shu X; Budinger TF; Forte TM
    Int J Pharm; 2007 Jan; 328(1):86-94. PubMed ID: 16959446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermal scalpel to target cancer.
    Everts M
    Expert Rev Med Devices; 2007 Mar; 4(2):131-6. PubMed ID: 17359220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designer therapies for glioblastoma multiforme.
    Sathornsumetee S; Rich JN
    Ann N Y Acad Sci; 2008 Oct; 1142():108-32. PubMed ID: 18990124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress in the study of drug delivery system based on nanoparticles to overcome multi-drug resistance].
    Chen JN; Shen Q; Li SS
    Yao Xue Xue Bao; 2009 Apr; 44(4):333-7. PubMed ID: 19545047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chapter 11 - Solid lipid nanoparticles for brain tumors therapy: State of the art and novel challenges.
    Brioschi AM; Calderoni S; Zara GP; Priano L; Gasco MR; Mauro A
    Prog Brain Res; 2009; 180():193-223. PubMed ID: 20302836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.